Board of Directors
Gary Kurtzman, MD
Managing Director, Safeguard Scientifics (NYSE:SFE)
Dr. Kurtzman has more than 25 years of experience as an entrepreneur, board member, financier and operator. As Managing Director of Healthcare at Safeguard Scientifics (NYSE:SFE), Dr. Kurtzman leverages his medical expertise to empower businesses to enhance their products, expand their services, and identify strategic partnership opportunities. Dr. Kurtzman has realized value for companies through a series of successful IPOs, M&A and turnaround transactions—most recently Shire’s acquisition of Safeguard’s partner company Advanced BioHealing for $750 million, in cash; and Eli Lilly’s acquisition of Safeguard’s partner company Avid Radiopharmaceuticals for $300 million, up front, with an additional $500 million payout dependent upon the achievement of future regulatory and commercial milestones. Dr. Kurtzman’s previous experiences include leadership roles at BioAdvance, Pluvita Corporation, Genovo, Avigen, and Gilead Sciences. Presently, Dr. Kurtzman is a lecturer in the Health Care Systems Department at the Wharton School at the University of Pennsylvania where he teaches entrepreneurship in life sciences. In addition, he is also a member of the board at Safeguard’s partner companies Alverix, Crescendo Bioscience, Good Start Genetics, Medivo and PixelOptics.
President, CEO and Director of Pacira Pharmaceuticals
Dave Stack is an experienced leader in the life sciences industry with a distinguished track record of success. He is currently the President, CEO and Director of Pacira Pharmaceuticals, Inc., and a Founding Partner of Stack Pharmaceuticals, Inc., a commercialization, marketing and strategy firm serving emerging healthcare companies. In addition, he is a Managing Director at MPM Capital.
From September 2001 until August 2004 he was President, Chief Executive Officer and Director of The Medicines Company (NASDAQ:MDCO). Prior to The Medicines Company he was the CEO of Stack Pharmaceutical, Inc., where MDCO was one of the primary customers. From May 1995 to December 1999, he served as the President and General Manager of Innovex, Inc. responsible for the Americas. Innovex Inc. was a commercial solutions company offering a full range of marketing, sales and clinical development capabilities to pharmaceutical and biotechnology customers. From April 1993 to May 1995, he was the Vice President of Business Development and Marketing for Immunomedics, Inc (NASDAQ:IMMU) a biopharmaceutical company focusing on monoclonal antibodies in infectious disease and oncology. From May 1992 to March 1993, he was the Director of Business Development and Planning for Infectious Disease, Oncology and Virology for Roche Labs where he was the Therapeutic World Leader of Infectious Disease. Prior to that he held various positions with Roche Labs for approximately 12 years and was a retail and hospital pharmacist for three years after graduating from Albany College of Pharmacy, he also holds a BS in Biology from Siena College.
Mr. Stack was recognized as the Ernst and Young Entrepreneur of the Year in 2003 (New Jersey Healthcare). He is a Director of PepTx, Inc.